These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Purple glove syndrome following intravenous phenytoin administration. Prince NJ; Hill C Arch Dis Child; 2011 Aug; 96(8):734. PubMed ID: 21628328 [No Abstract] [Full Text] [Related]
4. Purple glove syndrome caused by intravenous phenytoin: two case reports. Tsang CY; Ng JYW; Yuen SH; Lau IT; Leung YF Hong Kong Med J; 2019 Dec; 25(6):487-489. PubMed ID: 32127502 [No Abstract] [Full Text] [Related]
5. Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: mechanism still a dilemma. Jain RS; Nagpal K; Kumar S; Prakash S; Handa R Am J Emerg Med; 2015 Jan; 33(1):123.e5-6. PubMed ID: 25064142 [TBL] [Abstract][Full Text] [Related]
6. Purple glove syndrome: a dreadful complication of intravenous phenytoin administration. Lalla R; Malhotra HS; Garg RK; Sahu R BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22922927 [TBL] [Abstract][Full Text] [Related]
7. Early histopathologic changes in purple glove syndrome. Bhattacharjee P; Glusac EJ J Cutan Pathol; 2004 Aug; 31(7):513-5. PubMed ID: 15239684 [TBL] [Abstract][Full Text] [Related]
8. ["Purple glove syndrome." Severe soft tissue reaction following phenytoin infusion]. Cadenbach A; Röttger K; Müller MK Dtsch Med Wochenschr; 1998 Mar; 123(11):318-22. PubMed ID: 9540771 [TBL] [Abstract][Full Text] [Related]
9. Purple glove syndrome caused by oral administration of phenytoin. Yoshikawa H; Abe T; Oda Y J Child Neurol; 2000 Nov; 15(11):762. PubMed ID: 11108512 [TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Coplin WM; Rhoney DH; Lyons EA; Murry KR Neurology; 1999 Oct; 53(7):1611-2. PubMed ID: 10534289 [No Abstract] [Full Text] [Related]
11. A Rare Complication of Phenytoin Infusion in Newborn: Purple Glove Syndrome. Ulubaş Işık D; Demirel N; Erol S; Ünal S; Baş AY Balkan Med J; 2017 Dec; 34(6):584-585. PubMed ID: 29215341 [No Abstract] [Full Text] [Related]
12. [Purple glove syndrome]. Burneo de las Casas J; Barkley G Rev Neurol; 2000 Aug 16-31; 31(4):400. PubMed ID: 11008301 [No Abstract] [Full Text] [Related]
13. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. O'Brien TJ; Cascino GD; So EL; Hanna DR Neurology; 1998 Oct; 51(4):1034-9. PubMed ID: 9781525 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of the incidence of the purple glove syndrome. Burneo JG; Anandan JV; Barkley GL Epilepsia; 2001 Sep; 42(9):1156-9. PubMed ID: 11580764 [TBL] [Abstract][Full Text] [Related]
15. Compartment syndrome as a spectrum of purple glove syndrome following intravenous phenytoin administration in a young male: a case report and review of literature. Chhabra P; Gupta N; Kaushik A Neurol India; 2013; 61(4):419-20. PubMed ID: 24005736 [TBL] [Abstract][Full Text] [Related]
16. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. Scumpia AJ; Yahsou J; Cajina J; Cao C J Emerg Med; 2013 Feb; 44(2):e281-3. PubMed ID: 22980417 [No Abstract] [Full Text] [Related]
17. Intravenous phenytoin and percutaneous arterial cannulation: the purple-glove syndrome. Mahajan RP; Batra YK; Rajeev S Eur J Anaesthesiol; 2007 Oct; 24(10):900-1. PubMed ID: 17977106 [No Abstract] [Full Text] [Related]
18. Purple glove syndrome associated with intravenous phenytoin administration in a patient with severe mental and motor retardation. Sonohata M; Asami A; Tsunoda K; Hotokebuchi T J Orthop Sci; 2006 Jul; 11(4):409-11. PubMed ID: 16897209 [No Abstract] [Full Text] [Related]
19. Distal upper extremity edema and discoloration. Kirsch S; Bayard M; Darraj K Am Fam Physician; 2007 Mar; 75(6):889-91. PubMed ID: 17390602 [No Abstract] [Full Text] [Related]